Bayer will put some of its seed businesses up for sale an attempt to address likely antitrust concerns over its $66B merger with Monsanto, Bloomberg reports.
The Leverkusen, Germany-based company will send out information packages on three assets, which it may sell separately, to potential bidders, the people said, asking not to be identified because the deliberations are private. None of Monsanto’s assets will be sold in the process, they said.
Among the products being offered are the cottonseed business Bayer acquired from Monsanto for more than $300 million in 2007, as well as canola seed operations and LibertyLink, a herbicide-resistant crop gene, the people said. Representatives for Bayer and Monsanto declined to comment.
Bayer’s resolve to start selling assets before antitrust regulators have made recommendations highlights the German company’s drive to conclude the deal as quickly as possible. A sale of the three assets, which have overlaps with Monsanto’s products, was widely expected to avoid a run in with regulators. In cottonseed, US government data showed that Bayer and Monsanto together control about 58 percent of sales in the country.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Orders Google to Open Android App Store Amid Antitrust Pressure
Oct 7, 2024 by
CPI
Federal Judge Greenlights FTC’s Antitrust Lawsuit Against Amazon, Tosses Some State Claims
Oct 7, 2024 by
CPI
Supreme Court Rejects Uber and Lyft’s Appeal in California Gig Worker Suits
Oct 7, 2024 by
CPI
Supreme Court Sidesteps 5-Hour Energy Pricing Case, Allowing Antitrust Claims to Proceed
Oct 7, 2024 by
CPI
Tempur Sealy and Mattress Firm Argue FTC Proceedings Are Unconstitutional in New Suit
Oct 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh